TE_12623
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1HS_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | MCCC2 |
| Class | Chimeric |
| Coding | Non-coding, Other |
| Tumor-specific score | 364.05 |
| Counts of samples | TCGA_tumor:322; TCGA_normal:0; GTEx:0 |
| TSS | chr5(+):71610206 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_12623.21 | MCCC2 | Chimeric | Non-coding | Non-coding | chr5(+):71610207,71610334,71632121,71632185,71634943,71635042,71635151,71635246,71636104,71636167,71641003,71641023 |
| teRNA_12623.22 | MCCC2 | Chimeric | Non-coding | Non-coding | chr5(+):71610207,71610334,71632121,71632185,71634943,71635042,71635151,71635246,71641003,71642727,71643819,71643895,71646211,71646277,71649097,71649253,71650069,71650183,71652669,71652754,71656743,71656763 |
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
